Advances in Colorectal Cancer Therapy

Dear Colleagues,

Colorectal cancer is the 3rd most common cancer worldwide, with a mean age of diagnosis at around 71 years old. Recent data suggest an increased incidence of cases in young people. Moreover, despite improvements in prognosis thanks to targeted therapies over the past two decades, the rate of recurrence or resistance to treatment remains high. For instance, for stage 3, this rate reaches 30%, despite well-conducted curative treatment. Its complexity is in part related to the heterogeneity present within the tumor. Therefore, this Special Issue will consider articles on all types of research, from fundamental to translational and clinical, to shed light on the evolution of therapies in colon and rectal cancers and all the new diagnostic, prognostic, and theragnostic strategies that international research teams are currently developing.

Dr. Niki Christou
Dr. Mireille Verdier
Dr. Fabrice Lalloué
Topic Editors